QuickView for Deoxynucleoside kinase (biogroup)

1. L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
2. L1000 CMAP - T-ALL Jurkat cells with shRNA-mediated gene knockdown
3. Response to hypoxia in renal proximal tubule, breast, and coronary artery cells
4. L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)

There were no matches for Deoxynucleoside kinase

1. Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome
2. A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve…
3. Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in …
4. Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antire…
5. Metformin Reduce the Relapse Rate on Patients With B-cell Precursor (Ph+ Negative) Acute Lymphoblast…